Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | BLM | P54132 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574107 | 0.92 | ALDH1A1 (0.41) | TDP1 | |
| SCHEMBL5311847 | 0.80 | CA1 (0.32) | MAPTMAPK1TDP1L3MBTL1LMNA | |
| SCHEMBL5313148 | 0.79 | VDR (0.41) | MEN1LMNAKMT2A | |
| SCHEMBL574676 | 0.74 | ALDH1A1 (0.39) | TDP1 | |
| SCHEMBL574724 | 0.71 | CDK1 (0.35) | CA1CA2 | |
| SCHEMBL574593 | 0.69 | ALDH1A1 (0.33) | MAPTTDP1L3MBTL1CA1CA2 | |
| SCHEMBL574466 | 0.69 | ALDH1A1 (0.33) | MAPTTDP1L3MBTL1CA1CA2 | |
| SCHEMBL574611 | 0.66 | ALDH1A1 (0.44) | TDP1 | |
| SCHEMBL17601966 | 0.65 | ALDH1A1 (0.42) | TDP1 | |
| SCHEMBL11177788 | 0.64 | RAPGEF4 (0.44) | MAPTMAPK1TDP1L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10597352-B1 | Stable alkyl benzidine composition and methods of making and using same | OneStep Technologies Inc. (CA) | 2020-03-24 | — | — | US | claimed |
| US-4716110-A | Composition for assaying hydrogen peroxide | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 1987-12-29 | — | — | US | claimed |
| WO-2020257930-A1 | STABLE ALKYL BENZIDINE COMPOSITION AND METHODS OF MAKING AND USING SAME | OneStep Technologies Inc. (CA) | 2020-12-30 | — | — | WO | disclosed |
| US-10597352-B1 | Stable alkyl benzidine composition and methods of making and using same | OneStep Technologies Inc. (CA) | 2020-03-24 | — | — | US | disclosed |
| US-9228986-B2 | Simultaneous determination of multiple analytes in industrial water system | GENERAL ELECTRIC COMPANY (US) | 2016-01-05 | — | — | US | disclosed |
| EP-2601515-A1 | SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES IN INDUSTRIAL WATER SYSTEM | General Electric Company (US) | 2013-06-12 | — | — | EP | disclosed |
| US-20130122597-A1 | SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES IN INDUSTRIAL WATER SYSTEM | BL TECHNOLOGIES, INC. | 2013-05-16 | — | — | US | disclosed |
| WO-2012016350-A1 | SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES IN INDUSTRIAL WATER SYSTEM | GENERAL ELECTRIC COMPANY (US) | 2012-02-09 | — | — | WO | disclosed |
| US-20070224691-A1 | Composition for measuring concentration of residual chlorine | MIURA CO., LTD. | 2007-09-27 | — | — | US | disclosed |
| EP-1837653-A1 | Composition for measuring concentration of residual chlorine | MIURA CO., LTD. (JP) | 2007-09-26 | — | — | EP | disclosed |
| EP-1770394-A2 | Composition for measuring residual chlorine concentration | MIURA CO., LTD. (JP) | 2007-04-04 | — | — | EP | disclosed |
| US-20070072305-A1 | Composition for measuring residual chlorine concentration | MIURA CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| US-4716110-A | Composition for assaying hydrogen peroxide | EIKEN KAGAKU KABUSHIKI KAISHA (JP) | 1987-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10597352-B1 | Stable alkyl benzidine composition and methods of making and using same | C9, BBC3, CTRC | MAPT 4307/4885MAPK1 2759/4885TDP1 3846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.